Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CREXONT ER 87.5 MG-350 MG CAP

carbidopa and levodopa
$4.3618per EA
High Outlier

Strength

87.5; 350 mg/1; mg/1

Manufacturer

Amneal Pharmaceuticals LLC

NDC

64896097016

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

CARBIDOPA; LEVODOPA

Approval Type

New Drug (NDA)

FDA Application

NDA217186

On Market Since

8/9/2024

Pharmacological Classes

Amino Acids
Aromatic
Aromatic Amino Acid

Price History

1W

0.0%

1M

+0.0%

3M

+0.1%

6M

+0.4%

1Y

+5.9%

3Y

N/A

5Y

N/A

All

+5.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

RYTARY ER 36.25 MG-145 MG CAP
Brand
64896066243•Amneal Pharmaceuticals LLC
$2.7870
per EA
RYTARY ER 23.75 MG-95 MG CAP
Brand
64896066143•Amneal Pharmaceuticals LLC
$2.7980
per EA
RYTARY ER 48.75 MG-195 MG CAP
Brand
64896066343•Amneal Pharmaceuticals LLC
$2.8105
per EA
RYTARY ER 61.25 MG-245 MG CAP
Brand
64896066443•Amneal Pharmaceuticals LLC
$3.5009
per EA
DHIVY 25-100 MG TABLET
Brand
75854070101•Avion Pharmaceuticals, LLC
$3.6141
per EA
RYTARY ER 36.25 MG-145 MG CAP
Brand
64896066201•Amneal Pharmaceuticals LLC
$3.9779
per EA
RYTARY ER 23.75 MG-95 MG CAP
Brand
64896066101•Amneal Pharmaceuticals LLC
$3.9819
per EA
RYTARY ER 48.75 MG-195 MG CAP
Brand
64896066301•Amneal Pharmaceuticals LLC
$3.9834
per EA
RYTARY ER 61.25 MG-245 MG CAP
Brand
64896066401•Amneal Pharmaceuticals LLC
$4.9945
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy